Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Breathe Bravely is a non-profit organization dedicated to supporting individuals living with cystic fibrosis (CF) through innovative programs that focus on the breath and the voice. The organization is best known for its sings65 program, which provides personalized vocal training to CF patients to improve respiratory health and emotional well-being. Founded by Ashley Ballou-Bonnema, who lives with CF herself, the organization aims to empower the CF community through education, advocacy, and creative expression. Breathe Bravely operates as a support and wellness entity rather than a traditional pharmaceutical developer. Their initiatives include podcasts and community outreach designed to foster a sense of connection and resilience among those affected by the disease. By utilizing the art of singing, the organization provides a unique therapeutic approach to managing the physical and mental challenges of cystic fibrosis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Breathe Bravely.